Currently also: Chief Informatics and Technology Officer (CITO) at Pangea Botanica, London/UK and Berlin/Germany
Previous positions:
Director Digital Chemistry at NUVISAN Berlin
Associate Director Computational ADME and Safety (Clinical Pharmacology & Safety Sciences/Data Science and Artificial Intelligence - CPSS/DSAI) at AstraZeneca Cambridge
Co-founder of Healx Ltd.
Co-founder of PharmEnable Ltd.
- Committed to developing new life science data analysis methods (AI/ML/data science) and their application, primarily related to chemical biology, drug discovery and in silico toxicology
- Expertise comprises data ranging from chemical structure and gene expression data to phenotypic readouts and preclinical information, applied to both efficacy- and safety/tox-related questions
- Collaborating with academic research groups, as well as pharmaceutical, chemical, and consumer goods companies (Eli Lilly, AstraZeneca, GSK, BASF, Johnson&Johnson/Janssen, Unilever, ...)
- Co-founder/founding CTO and current SAB member of Healx Ltd. (data-driven drug repurposing for rare diseases, and beyond); co-founder of PharmEnable Ltd.; SAB member of Lhasa Ltd. (toxicology and metabolism prediction) and Cresset Ltd.
- Coordinator of the Computational & In Silico Toxicology Specialty Section of the British Toxicology Society (BTS)
- Steering Committee Member of the Cambridge Alliance on Medicines Safety (CAMS)
- Currently leading a group of ca. 15 PhD students, postdocs, project students and visitors at the Centre for Molecular Informatics at the University of Cambridge, https://www-cmi.ch.cam.ac.uk/centre-molecular-informatics
Publications
Collaboration-based function prediction in protein-protein interaction networks
Lecture Notes in Computer Science
(2011)
7014 LNCS
318
(doi: 10.1007/978-3-642-24800-9_30)
Proteochemometric modeling as a tool to design selective compounds and for extrapolating to novel targets
RSC Medicinal Chemistry
(2011)
2
16
(doi: 10.1039/c0md00165a)
Computational Approaches in Cheminformatics and Bioinformatics
Computational Approaches in Cheminformatics and Bioinformatics
(2011)
Combining Aggregation with Pareto Optimization: A Case Study in Evolutionary Molecular Design
Lecture Notes in Computer Science Including Subseries Lecture Notes in Artificial Intelligence and Lecture Notes in Bioinformatics
(2010)
5467
453
(doi: 10.1007/978-3-642-01020-0_36)
Virtual Activity Profiling of Bioactive Molecules by 1D Fingerprinting.
Molecular Informatics
(2010)
29
773
(doi: 10.1002/minf.201000075)
How similar are those molecules after all? Use two descriptors and you will have three different answers
Expert opinion on drug discovery
(2010)
5
1141
(doi: 10.1517/17460441.2010.517832)
Bayesian Methods in Virtual Screening and Chemical Biology
Methods in molecular biology (Clifton, N.J.)
(2010)
672
175
(doi: 10.1007/978-1-60761-839-3_7)
Scaffold diversity analysis using scaffold retrieval curves and an entropy-based measure
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY
(2010)
240
Nonsubjective clustering scheme for multiconformer databases
ABSTR PAP AM CHEM S
(2010)
240
A novel chemogenomics analysis of G protein-coupled receptors (GPCRs) and their ligands: a potential strategy for receptor de-orphanization.
BMC bioinformatics
(2010)
11
316
(doi: 10.1186/1471-2105-11-316)
- ‹ previous
- Page 34
